InQpharm is a bio-pharmaceutical company that engages in the acquisition, research/development and commercialization of unique natural compounds with nutritional and therapeutic properties for the nutritional, animal health and medical device/pharmaceutical markets.

As a bio-pharmaceutical incubator, InQpharm acquires exploration and commercialization rights of novel biological therapeutic compounds, usually from small scale innovators and research institutions.

InQpharm adds value to such compounds through strong branding and conceptialisation, intelligent Intellectual Property work, by raising production standards to a pharmaceutically acceptable standard where necessary and by conducting industry standard safety and proof of principle studies, both pre-clinical and clinical, before making a decision on how it is going to commercialise each technology. InQpharm distributes its products in more than 35 markets at present.

InQpharm is an operationally profitable company that commercializes its compounds and technologies at the earliest possible opportunity through its Nutritional (functional food & nutraceutical) and Animal Health Business Units, thus making the company less dependent on constant fund raising through equity partners. InQpharm is a market leader in Europe in the new category of oral medical devices and is certified to ISO9001:2000 and ISO13485:2003.

The company's business model revolutionizes the drug discovery process, cutting typical clinical research cycles by many years, depending on existing supportive data on the compound/technology and on the stage/timing of commercialization.

InQpharm's current compounds/technologies cover Anti-microbial, Immuno-modulating, Anti-inflammatory and Anti-Obesity applications. InQpharm's medical device technologies cover Obesity, Allergic Rhinitis, Insomnia, Migrane and Erectile Dysfunction."

Contact person: Ravindran Ragunathan

www.inqpharm.com